時間 | 主題 | ||||
---|---|---|---|---|---|
PD7-1: Oncological results of radical prostatectomy in high risk group prostate patients: real world experience from Taiwan population
講者:
蔡禮賢
座長:
盧星華, 陳忠信 |
蔡禮賢 |
盧星華, 陳忠信 |
|||
PD7-2: Medium-term outcomes after whole-gland high-intensity focused ultrasound for the treatment of localized prostate cancer: A single institution experience
講者:
吳彥廷
座長:
盧星華, 陳忠信 |
吳彥廷 |
盧星華, 陳忠信 |
|||
PD7-3: Management of mCRPC with second-line hormone therapies: A single-hospital experience
講者:
莊毓峰
座長:
盧星華, 陳忠信 |
莊毓峰 |
盧星華, 陳忠信 |
|||
PD7-4: The prognostic impact of DDR2 overexpression in patients with urothelial carcinoma
講者:
李威明
座長:
盧星華, 陳忠信 |
李威明 |
盧星華, 陳忠信 |
|||
PD7-5: Identification of potential genes in upper tract urothelial carcinoma by using next-generation sequencing and bioinformatics analysis
講者:
李香瑩
座長:
盧星華, 陳忠信 |
李香瑩 |
盧星華, 陳忠信 |
|||
PD7-6: Application of risk models to predict outcomes in non-muscle invasive bladder urothelial carcinoma patient after transurethral tumor resection- external validation in Taiwan
講者:
陳昱光
座長:
盧星華, 陳忠信 |
陳昱光 |
盧星華, 陳忠信 |